Dr. Sankar is a physician in Life Sciences industry involved in the clinical development of innovative therapies in Oncology. Being a clinician and strong passion for science has helped him to work amongst some of the best scientific minds in this industry. He is also proud to state that he was part of the development team involved in 3 successful NDA submissions including 2 blockbuster drugs in oncology.( one for solid tumors and the other for B Cell malignancy) His extensive tenure in the industry and working with major industry players have provided him with excellent team management skills and relationship building helping him to connect with corporates, academia’s research centers and organizations to identify clinical and strategic needs to implement a successful clinical development plan.
Dr. Sankar is a very skilled professional who can connect the various dots needed for a drug approval & development strategy needed for successful filings. He holds active memberships with ASCO, ASH, EHA, ESMO, DIA, SOCRA, EPPIC Global, and Tie Silicon Valley and he has served in various sub committees within DIA including Clinical trial design, Clinical study end points, Protocol writing and Quality risk management.
Dr. Sankar is also very passionate about technology and science based innovation and development in the field of health care, drug discovery, research and development Areas of therapeutic expertise include Oncology including hematological and solid tumors, immunology, respiratory and CNS.
During his tenure Dr. Sankar has been part of 2 successful new drug applications in the oncology therapeutic area of which one of them was considered as a breakthrough designation drug.
Dr. Sankar is very passionate in supporting noble causes supporting human health, social equality, education and mentoring opportunities.
Life science, biotech
Clinical development of innovative therapies in Oncology
Universities Mentored For
Rice University, University of Michigan